176 related articles for article (PubMed ID: 10525927)
21. The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study.
Huang M; Zhang X; Chen S; Sun Y; Xiao Y; Sun J; Huang M; Chen S; Liu F
Pediatr Cardiol; 2013 Mar; 34(3):680-5. PubMed ID: 23108482
[TBL] [Abstract][Full Text] [Related]
22. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.
Macdonald PS; Keogh AM; Aboyoun CL; Lund M; Amor R; McCaffrey DJ
J Am Coll Cardiol; 1999 Mar; 33(4):924-31. PubMed ID: 10091817
[TBL] [Abstract][Full Text] [Related]
23. Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma.
Kotlyar E; Keogh AM; Macdonald PS; Arnold RH; McCaffrey DJ; Glanville AR
J Heart Lung Transplant; 2002 Dec; 21(12):1290-5. PubMed ID: 12490274
[TBL] [Abstract][Full Text] [Related]
24. Heart rate variability and baroreflex sensitivity in idiopathic dilated cardiomyopathy.
Hoffmann J; Grimm W; Menz V; Müller HH; Maisch B
Heart; 2000 May; 83(5):531-8. PubMed ID: 10768902
[TBL] [Abstract][Full Text] [Related]
25. Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy.
Oflaz MB; Balli S; Kibar AE; Ece I; Akdeniz C; Tuzcu V
Med Sci Monit; 2013 May; 19():366-72. PubMed ID: 23686300
[TBL] [Abstract][Full Text] [Related]
26. A randomised, placebo-controlled trial of carvedilol in early familial dilated cardiomyopathy.
Yeoh T; Hayward C; Benson V; Sheu A; Richmond Z; Feneley MP; Keogh AM; Macdonald P; Fatkin D
Heart Lung Circ; 2011 Sep; 20(9):566-73. PubMed ID: 21763198
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy.
Agarwal AK; Venugopalan P
Eur J Heart Fail; 2001 Aug; 3(4):437-40. PubMed ID: 11511429
[TBL] [Abstract][Full Text] [Related]
28. Effects of bisoprolol on heart rate variability in heart failure.
Pousset F; Copie X; Lechat P; Jaillon P; Boissel JP; Hetzel M; Fillette F; Remme W; Guize L; Le Heuzey JY
Am J Cardiol; 1996 Mar; 77(8):612-7. PubMed ID: 8610612
[TBL] [Abstract][Full Text] [Related]
29. Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial.
Cice G; Ferrara L; Di Benedetto A; Russo PE; Marinelli G; Pavese F; Iacono A
J Am Coll Cardiol; 2001 Feb; 37(2):407-11. PubMed ID: 11216954
[TBL] [Abstract][Full Text] [Related]
30. The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure.
Yildirir A; Sade E; Tokgozoglu L; Oto A
Eur J Heart Fail; 2001 Dec; 3(6):717-21. PubMed ID: 11738224
[TBL] [Abstract][Full Text] [Related]
31. [Correlation between cardiac autonomic activity and compromise of left ventricular function in dilated cardiomyopathy].
Hoffmann J; Grimm W; Menz V; Maisch B
Z Kardiol; 2000 Feb; 89(2):84-92. PubMed ID: 10768276
[TBL] [Abstract][Full Text] [Related]
32. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
[TBL] [Abstract][Full Text] [Related]
33. Long-term carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failure.
Goldsmith RL; Bigger JT; Bloomfield DM; Krum H; Steinman RC; Sackner-Bernstein J; Packer M
Am J Cardiol; 1997 Oct; 80(8):1101-4. PubMed ID: 9352991
[TBL] [Abstract][Full Text] [Related]
34. Ivabradine improves heart rate variability in patients with nonischemic dilated cardiomyopathy.
Kurtoglu E; Balta S; Karakus Y; Yasar E; Cuglan B; Kaplan O; Gozubuyuk G
Arq Bras Cardiol; 2014 Oct; 103(4):308-14. PubMed ID: 25119894
[TBL] [Abstract][Full Text] [Related]
35. Rapid carvedilol up-titration in hospitalized patients with left ventricular systolic dysfunction--data from the Carvedilol in Hospital: Up-titration Limits after Acute Patients Admission registry.
Martínez-Sellés M; Datino T; Alhama M; Barrueco N; Castillo I; Fernández-Avilés F
J Cardiovasc Med (Hagerstown); 2010 May; 11(5):352-8. PubMed ID: 20154635
[TBL] [Abstract][Full Text] [Related]
36. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.
Kumar A; Choudhary G; Antonio C; Just V; Jain A; Heaney L; Papp MA
Am Heart J; 2001 Sep; 142(3):512-5. PubMed ID: 11526366
[TBL] [Abstract][Full Text] [Related]
37. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial.
Basu S; Senior R; Raval U; van der Does R; Bruckner T; Lahiri A
Circulation; 1997 Jul; 96(1):183-91. PubMed ID: 9236433
[TBL] [Abstract][Full Text] [Related]
39. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
Tatli E; Kurum T
Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
[TBL] [Abstract][Full Text] [Related]
40. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience.
Bruns LA; Chrisant MK; Lamour JM; Shaddy RE; Pahl E; Blume ED; Hallowell S; Addonizio LJ; Canter CE
J Pediatr; 2001 Apr; 138(4):505-11. PubMed ID: 11295713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
